Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares were up 5.3% during mid-day trading on Wednesday . The company traded as high as $10.00 and last traded at $10.00. Approximately 1,481 shares changed hands during trading, a decline of 100% from the average daily volume of 1,486,525 shares. The stock had previously closed at $9.50.
Analyst Ratings Changes
Separately, StockNews.com began coverage on Veradigm in a research report on Wednesday, December 11th. They set a “hold” rating for the company. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, Veradigm currently has an average rating of “Hold” and a consensus price target of $11.75.
View Our Latest Research Report on MDRX
Veradigm Stock Up 2.6 %
Institutional Trading of Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is a buyback in stocks? A comprehensive guide for investors
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Invest in Biotech Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.